Tildrakizumab for treatment of moderate to severe psoriasis: an expert opinion of efficacy, safety, and use in special populations

.

Source: Expert Opinion on Biological Therapy - October 12, 2021 Category: Drugs & Pharmacology Authors: Marco Galluzzo Andrea Chiricozzi Elisa Cinotti Giovanna Brunasso Maurizio Congedo Maria Esposito Chiara Franchi Giovanna Malara Alessandra Narcisi Stefano Piaserico Rossana Tiberio Giuseppe Argenziano Gabriella Fabbrocini Aurora Parodi Source Type: research